FDA representatives have agreed to meet on Nov 9 with APC and other pharmacy organization leaders about FDA’s recent apparent reclassification of desiccated thyroid extract (DTE) as a biologic.
On December 14, FDA is hosting a webinar, "What to Expect after an Inspection: 483s, Responses and Beyond."
The pre-enforcement period was originally scheduled to end on October 27, 2022.
A recent email campaign has resulted in 19 additional contributions—totaling more than $16,000—to APC’s Save Compounded Hormones Campaign. It has also resulted in more than 70 new patient testimonials this week at compounding.com
Will you please tell us which compounding software you’re using? This short survey will only take a few minutes.
APC offers a pharmacy/facility membership (PFM) as an alternative to purchasing several individual memberships.
Did they or didn’t they? Did USP take seriously input from APC (as well as that of APhA, NCPA, and numerous other pharmacy stakeholder groups)?
Jack Korbutov says the system is already paying dividends.
The Outsourcing Facilities Association announced this week that it reached a settlement agreement with the FDA.
Eight members of Congress wrote to FDA Center for Veterinary Medicine director Dr. Steven Solomon this week to express concern that CVM’s GFI 256 on animal compounding may result in delayed care for veterinary patients.
FOLLOW US
